CAMBRIDGE, Mass. — Cognito Therapeutics has partnered with the Initiative to Change the “D-Word” and committed to eliminating the use of the term “dementia” across all of its internal and external communications, the company announced.
The move is aimed at promoting more precise, patient-centered language that reduces stigma and encourages earlier recognition of cognitive changes, according to the late clinical-stage neurotechnology company.
Cognito said the collaboration reflects a broader effort to modernize how neurodegenerative conditions are discussed, with a focus on improving how patients and families engage with care and seek medical support.
“Clear, precise language can make it easier for individuals and families to seek help early,” said Christian Howell, CEO of Cognito Therapeutics. “Our mission is to deliver a therapy that slows decline and helps people maintain independence. Retiring the word ‘dementia’ reflects our commitment to communication that supports earlier engagement with clinicians and more informed care decisions.”
The company is developing non-invasive therapies designed to engage brain network activity associated with preserving cognition, daily function, and brain structure. As part of the initiative, Cognito is updating its terminology to better align with current neuroscience and clinical practice.
Mike Zuendel, Founder and Advocate-in-Chief of the Initiative to Change the “D-Word,” said the partnership highlights how companies can lead efforts to reduce stigma in healthcare communication.
“Cognito is showing how companies can lead by pairing scientific rigor with thoughtful communication,” Zuendel said. “Choosing terminology that is specific and respectful helps reduce stigma and encourages earlier action, which is critical for individuals experiencing cognitive change.”
Cognito said it has already removed the term “dementia” from scientific materials, patient resources, clinical study communications, and public-facing content, replacing it with language intended to be clearer and less stigmatizing while supporting individuals living with Alzheimer’s disease and related neurodegenerative conditions.
